FDA Clearance Tracker · P080004-S047
iSert Preloaded IOL System: iSert 250, iSert 251, iSert 230, iSert 231, IPure Preloaded IOL System / Model B1PC (Clear
Last checked: Nov 20, 2026Latest source record: Oct 25, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 25, 2023
Approved
Time to decision
57 days
Received Aug 29, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080004-S047
- Device name
- iSert Preloaded IOL System: iSert 250, iSert 251, iSert 230, iSert 231, IPure Preloaded IOL System / Model B1PC (Clear
- Applicant
- Hoya Surgical Optics, Inc.
- Applicant location
- Chino Hills, CA
- Received
- Aug 29, 2023
- Decided
- Oct 25, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P080004
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for a button manufacturing site located at HOYA Lamphun Ltd., 75/2 Moo 4, Tambol Banklang, Amphur, Muang, Lamphun, 51000, Thailand
Source documents
Other decisions for Hoya Surgical Optics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.